Wolpert, Katherine H. MD∗; Kodish, Ian MD, PhD†; Kim, Soo-Jeong MD†‡; Uspal, Neil G. MD∗
From the ∗Assistant Professor (Wolpert) and Associate Professor (Uspal), Division of Emergency Medicine, Department of Pediatrics, University of Washington
†Associate Professor (Kim and Kodish), Department of Psychiatry and Behavioral Sciences, University of Washington
‡Seattle Children's Autism Center, Seattle, WA.
Dr. Uspal discloses that the U.S. Food and Drug Administration has not approved the use of olanzapine for the treatment of agitation in children, as discussed in this article. Please consult the product’s labeling for approved information.
Reprints: Katherine Wolpert, MD, 4800 Sand Point Way NE, Mail-Stop MB.7.520 Seattle WA, 98105 (e-mail: [email protected]).
